VAP-B/C Inhibitors

VAP-B/C inhibitors are chemical compounds designed to target and inhibit the function of VAP-B and VAP-C, which are members of the VAMP-associated protein (VAP) family. These proteins are involved in critical cellular processes such as membrane trafficking, lipid transport, and the maintenance of endoplasmic reticulum (ER) structure. VAP-B and VAP-C function by interacting with proteins containing FFAT (two phenylalanines in an acidic tract) motifs, facilitating the formation of membrane contact sites between the ER and other organelles like the Golgi apparatus, mitochondria, and endosomes. By regulating lipid exchange and protein transport, VAP-B and VAP-C play essential roles in maintaining cellular homeostasis and membrane dynamics. Inhibitors of VAP-B/C disrupt these interactions, leading to alterations in membrane contact site formation and cellular trafficking pathways.

On a molecular level, VAP-B/C inhibitors are likely to target the MSP (major sperm protein) domain or the coiled-coil domain of these proteins, which are critical for their interactions with FFAT motif-containing proteins. By blocking these interactions, the inhibitors prevent the proper formation of membrane contact sites, disrupting lipid and protein transport between organelles. This can lead to changes in cellular functions such as lipid metabolism, autophagy, and ER morphology. In experimental settings, VAP-B/C inhibitors are valuable tools for studying the mechanisms of intracellular transport and organelle communication. They provide insights into how membrane contact sites are regulated and how disruptions in these processes can impact broader cellular functions. Researchers use VAP-B/C inhibitors to investigate the complex interactions between organelles, allowing for a deeper understanding of the molecular mechanisms underlying cellular organization and homeostasis.